Table 2.
Prevalence of molecular markers associated with Plasmodium falciparum resistance to chloroquine and sulphadoxine-pyrimethamine in study population according to age
| Molecular marker | n (%) |
<10 years |
≥10 years |
P value |
|---|---|---|---|---|
| n (%) | n (%) | |||
| T76 (n = 195) |
56 (28.7) |
38 (31.1) |
18 (24.7) |
0.42 |
| Y86 (n = 193) |
47 (24.4) |
26 (22) |
21 (28) |
0.44 |
| T76Y86 (n = 193) |
10 (4.6) |
6 (4.4) |
4 (4.8) |
1.00 |
| G437 (n = 192) |
91 (47.4) |
56 (47.5) |
35 (47.3) |
0.90 |
| E540 (n = 192) |
0 (0) |
0 (0) |
0 (0) |
|
| I51 (n = 194) |
125 (64.4) |
76 (61.8) |
49 (69) |
0.39 |
| R59 (n = 194) |
50 (25.8) |
29 (24.2) |
21 (28.4) |
0.63 |
| N108 (n = 194) |
35 (18) |
24 (20.2) |
11 (14.7) |
0.44 |
| IRN (n = 194) |
3 (1.5) |
1 (0.7) |
2 (2.4) |
0.56 |
| IRNG (192) | 1 (0.5) | 0 | 1 (1.2) | 0.38 |